CellCentric key collaborator awarded FRS

Posted on May 24th 2010

Professor Wolf Reik Head of the Laboratory of Developmental Genetics and Imprinting at the Babraham Institute has been elected to the Fellowship of the Royal Society. Professor Reik is a world leading authority in the field of epigenetics.

CellCentric has been working with Prof Reik since 2006. The company and his laboratory have ongoing collaborative research looking at the mechanisms of epigenetic reprogramming. Patents from his work have been filed and licensed to the company.

The Royal Society is the UK's leading scientific organization; The Fellowship comprises more than 1,300 of the most distinguished scientists from the UK, the commonwealth and the Republic of Ireland.

Professor Reik commented, "I am delighted with this honour and the recognition it gives to the work my team has been involved in over the years at Babraham."

About Professor Wolf Reik

Wolf Reik is Head of the Laboratory of Developmental Genetics and Imprinting at the Babraham Institute, an institute of BBSRC, where he is researching epigenetic mechanisms of gene regulation in early embryos, germ cells, and stem cells, in particular in the role of epigenetic reprogramming in stem cell plasticity. He has a joint appointment on the managing board of the Centre for Trophoblast Research at the University of Cambridge and is the inaugural Professor of Epigenetics at the University of Cambridge.

After receiving his MD in Germany, he did postgraduate studies with Rudolf Jaenisch (on retroviruses, epigenetics, DNA methylation) and then postdoctoral work with Azim Surani (on genomic imprinting) in Cambridge as an EMBO Fellow. He has published more than 150 research papers, and received a number of prizes and distinctions for his work, including the Wellcome Prize of Physiology. He is an elected member of EMBO and a Fellow of the Academy of Medical Sciences. He is a member of editorial boards of several academic journals and of Faculty 1000 Biology. He also sits on the Executive Board of The Epigenome EU Network of Excellence, the scientific advisory board of the Centre for Genomic Regulation in Barcelona and the Curie Institute in Paris, and is a consultant to CellCentric, Cambridge.

For further details on this release, please contact:

Will West, CEO
CellCentric
Tel: + 44 (0) 1799 531 130
will.west@cellcentric.com